Daniel Busby

Stock Analyst at RBC Capital

(2.72)
# 2,120
Out of 5,045 analysts
6
Total ratings
66.67%
Success rate
22.25%
Average return

Stocks Rated by Daniel Busby

Verrica Pharmaceuticals
May 25, 2022
Downgrades: Sector Perform
Price Target: $160$40
Current: $3.61
Upside: +1,008.03%
Pfizer
Jun 17, 2021
Maintains: Sector Perform
Price Target: $43$44
Current: $24.29
Upside: +81.14%
MannKind
May 14, 2021
Initiates: Sector Perform
Price Target: $5
Current: $5.54
Upside: -9.75%
AbbVie
May 3, 2021
Reiterates: Outperform
Price Target: $135
Current: $225.14
Upside: -40.04%